ANCA-associated vasculitides: Pathogenetic aspects and current evidence-based therapy

被引：11

作者：

Holle, J. U. ^{[1
]}

Gross, W. L.

机构：

[1] Univ Hosp Schleswig Holstein, Dept Rheumatol, D-23538 Lubeck, Germany

来源：

JOURNAL OF AUTOIMMUNITY | 2009年 / 32卷 / 3-4期

关键词：

ANCA-associated vasculitis; Wegener's granulomatosis; Evidence-based therapy; EULAR recommendations; CHURG-STRAUSS-SYNDROME; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; REFRACTORY WEGENERS-GRANULOMATOSIS; ANTIBODY-ASSOCIATED VASCULITIS; TNF-ALPHA BLOCKADE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TERM-FOLLOW-UP; RANDOMIZED-TRIAL; MYCOPHENOLATE-MOFETIL; POLYARTERITIS-NODOSA;

D O I：

10.1016/j.jaut.2009.02.019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A lot of progress has been made regarding the therapy of ANCA-associated vasculitides in the past decades. Cyclophosphamide still is standard therapy for remission induction in generalized disease, however, duration and cumulative dose of cyclophosphamide have been curtailed successfully to reduce toxicity. MTX is a safe alternative for remission induction in early systemic disease and medications available for remission maintenance have been extended. Rituximab and TNFalpha-antagonists represent promising options for refractory disease. The current evidence of therapy of ANCA-associated vasculitides is summarized in this review. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：163 / 171

页数：9

共 50 条

[31] Pathogenetic and Clinical Aspects of Anti-neutrophil Cytoplasmic Autoantibody-Associated vasculitides [J].

Lamprecht, Peter ;

Kerstein, Anja ;

Klapa, Sebastian ;

Schinke, Susanne ;

Karsten, Christian M. ;

Yu, Xinhua ;

Ehlers, Marc ;

Epplen, Joerg T. ;

Holl-Ulrich, Konstanze ;

Wiech, Thorsten ;

Kalies, Kathrin ;

Lange, Tanja ;

Laudien, Martin ;

Laskay, Tamas ;

Gemoll, Timo ;

Schumacher, Udo ;

Ullrich, Sebastian ;

Busch, Hauke ;

Ibrahim, Saleh ;

Fischer, Nicole ;

Hasselbacher, Katrin ;

Pries, Ralph ;

Petersen, Frank ;

Weppner, Gesche ;

Manz, Rudolf ;

Humrich, Jens Y. ;

Nieberding, Relana ;

Riemekasten, Gabriela ;

Mueller, Antje .

FRONTIERS IN IMMUNOLOGY, 2018, 9

[32] Rituximab for ANCA-associated vasculitides [J].

Guillevin, L. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) :S118-S121

[33] Adverse effects of therapy for ANCA-associated vasculitis [J].

Turnbull, Jennifer ;

Harper, Lorraine .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (03) :391-401

[34] Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides? [J].

Toyoda, Task ;

Yates, Max ;

Watts, Richard A. .

CURRENT RHEUMATOLOGY REPORTS, 2022, 24 (04) :111-117

[35] ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance [J].

Terrier, Benjamin ;

Charles, Pierre ;

Aumaitre, Olivier ;

Belot, Alexandre ;

Bonnotte, Bernard ;

Crabol, Yoann ;

Durel, Cecile-Audrey ;

Ebbo, Mikael ;

Jourde-Chiche, Noemie ;

Lega, Jean-Christophe ;

Puechal, Xavier ;

Pugnet, Gregory ;

Quemeneur, Thomas ;

Ribi, Camillo ;

Samson, Maxime ;

Vandergheynst, Frederic ;

Guillevin, Loic .

PRESSE MEDICALE, 2020, 49 (03)

[36] Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data [J].

Biedron, Grzegorz ;

Wludarczyk, Anna ;

Wawrzycka-Adamczyk, Katarzyna ;

Wojcik, Krzysztof ;

Sznajd, Jan ;

Zdrojewski, Zbigniew ;

Masiak, Anna ;

Czuszynska, Zenobia ;

Majdan, Maria ;

Jeleniewicz, Radoslaw ;

Klinger, Marian ;

Jakuszko, Katarzyna ;

Rowaiye, Olumide Olatubosun ;

Brzosko, Marek ;

Brzosko, Iwona ;

Debska-Slizien, Alicja ;

Storoniak, Hanna ;

Tlustochowicz, Witold ;

Kur-Zalewska, Joanna ;

Wislowska, Malgorzata ;

Madej, Marta ;

Hawrot-Kawecka, Anna ;

Gluszko, Piotr ;

Kucharz, Eugeniusz J. ;

Musial, Jacek ;

Szczeklik, Wojciech .

ADVANCES IN MEDICAL SCIENCES, 2020, 65 (01) :156-162

[37] ANCA-associated vasculitides-lessons from the adult literature [J].

Vamvakopoulos, Joannis ;

Savage, Caroline O. ;

Harper, Lorraine .

PEDIATRIC NEPHROLOGY, 2010, 25 (08) :1397-1407

[38] Evolution of Therapy for ANCA-Associated Vasculitis with Kidney Involvement [J].

Rajasekaran, Arun ;

Rizk, Dana V. .

KIDNEY360, 2023, 4 (12) :1794-1805

[39] Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors [J].

Kostianovsky, A. ;

Hauser, T. ;

Pagnoux, C. ;

Cohen, P. ;

Daugas, E. ;

Mouthon, L. ;

Miossec, P. ;

Cordier, J-F ;

Guillevin, L. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) :S77-S82

[40] Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity [J].

Solans-Laque, Roser ;

Fraile, Guadalupe ;

Rodriguez-Carballeira, Monica ;

Caminal, Luis ;

Castillo, Maria J. ;

Martinez-Valle, Ferran ;

Saez, Luis ;

Rios, Juan J. ;

Solanich, Xavier ;

Oristrell, Joaquim ;

Pasquau, Francisco ;

Fonseca, Eva ;

Zamora, Monica ;

Callejas, Jose L. ;

Frutos, Begona ;

Abdilla, Monica ;

Fanlo, Patricia ;

Garcia-Sanchez, Isabel ;

Lopez-Dupla, Miguel ;

Sopena, Bernardo ;

Perez-Iglesias, Almudena ;

Bosch, Josep A. .

MEDICINE, 2017, 96 (08)

← 1 2 3 4 5 →